INSM1 and neuroblastoma: Its protein nuclear expression has been documented in 84% of neuroblastomas, with a suggested association with clinical outcome, being the three INSM1-negative neuroblastoma patients in the published study all alive with a median survival of 15 years as opposed to a median of 5 years in 9 out of 13 INSM1-positive neuroblastoma patients [28].